Absence of BRAF gene mutations differentiates Spitz nevi from malignant melanoma

Anticancer Research

Volumn 24, Issue 4, 2004, Pages 2415-2418

  Mihic Probst, Daniela ^a   Perren, Aurel ^a   Schmid, Sonja ^a   Saremaslani, Parvin ^a   Komminoth, Paul ^b   Heitz, Philipp U ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Kantonsspital Baden   (Switzerland)

Author keywords

BRAF gene; Malignant melanoma; Spitz nevus

Indexed keywords

PROTEIN SERINE THREONINE KINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAF GENE; CANCER DIAGNOSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DIFFERENTIAL DIAGNOSIS; EXON; FEMALE; GENE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JUVENILE MELANOMA; MALE; MELANOMA; NEVUS; PRIORITY JOURNAL; SKIN TUMOR;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; MELANOMA; MUTATION; NEVUS, EPITHELIOID AND SPINDLE CELL; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; SKIN NEOPLASMS;

EID: 4444384601     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Spitz S: Melanomas of childhood. Am J Pathol (24): 591-609, 1948.
2. Barnhill RL, Argenyi ZB, From L, Glass LF, Maize JC, Mihm MC Jr, Rabkin MS, Ronan SG, White WL and Piepkorn M: Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 30(5): 513-520, 1999.
3. Spatz A, Ruiter D, Hardmeier T, Renard N, Wechsler J, Bailly C, Avril MF, Kwee H, Bastian BC, Hill C, De Potter C and Prade M: Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects. Int J Cancer 68(3): 317-324, 1996.
4. van Dijk MC, Rombout PD, Mooi WJ, van de Molengraft FJ, van Krieken JH, Ruiter DJ and Ligtenberg MJ: Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours. J Pathol 197(2): 170-178, 2002.
5. Guttman-Yassky E, Bergman R, Manov L, Sprecher E, Shaefer Y and Kerner H: Human telomerase. RNA component expression in Spitz nevi, common melanocytic nevi, and malignant melanomas. J Cutan Pathol 29(6): 341-346, 2002.
6. Ribe A and McNutt NS: S100A6 Protein expression is different in Spitz nevi and melanomas. Mod Pathol 16(5): 505-511, 2003.
7. Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G and Offidani A: Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. Cancer 95(9): 1963-1970, 2002.
8. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR and Futreal PA: Mutations of the BRAF gene in human cancer. Nature 417(6892): 949-954, 2002.
9. Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, Einhorn E, Herlyn M, Minna J, Nicholson A, Roth JA, Albelda SM, Davies H, Cox C, Brignell G, Stephens P, Futreal PA, Wooster R, Stratton MR and Weber BL: BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 62(23): 6997-7000, 2002.
10. Gorden A, Osman I, Gai W, He D, Huang W, Davidson A, Houghton AN, Busam K and Polsky D: Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. Cancer Res 63(14): 3955-3957, 2003.
11. Perren A, Roth J, Muletta-Feurer S, Saremaslani P, Speel EJ, Heitz PU and Komminoth P: Clonal analysis of sporadic pancreatic endocrine tumours. J Pathol 186(4): 363-371, 1998.
12. Komminoth P, Kunz E, Hiort O, Schroder S, Matias-Guiu X, Christiansen G, Roth J and Heitz PU: Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. Am J Pathol 145(4): 922-929, 1994.
13. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM and Meltzer PS: High frequency of BRAF mutations in nevi. Nat Genet 33(1): 19-20, 2003.
14. Bastian BC, Wesselmann U, Pinkel D and Leboit PE: Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 113(6): 1065-1069, 1999.
15. Bastian BC, LeBoit PE and Pinkel D: Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 157(3): 967-972, 2000.
16. Bastian BC, Kashani-Sabet M, Hamm H, Godfrey T, Moore DH 2nd, Brocker EB, LeBoit PE and Pinkel D: Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 60(7): 1968-1973, 2000.
17. van Elsas A, Zerp SF, van der Flier S, Kruse KM, Aarnoudse C, Hayward NK, Ruiter DJ and Schrier PI: Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol 149(3): 883-893, 1996.
18. Marais R and Marshall CJ: Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv 27: 101-125, 1996.
19. Yazdi AS, Palmedo G, Flaig MJ, Puchta U, Reckwerth A, Rutten A, Mentzel T, Hugel H, Hantschke M, Schmid-Wendtner MH, Kutzner H and Sander CA: Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol 121(5): 1160-1162, 2003.
20. Dong J, Phelps RG, Qiao R, Yao S, Benard O, Ronai Z and Aaronson SA: BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res 63(14): 3883-3885, 2003.